Mirna announces USPTO allows claims to medicinal reference of let-7 miRNA
Posted in Medical Patent on October 21st, 2010Mirna Therapeutics, Inc. announced today that the USPTO has allowed claims joint to the curative dedication of let-7 in the dictate of oncogenes. The claims develop from from a charter operation that was submitted pre-eminently Yale University and exclusively licensed to Mirna coupled to the pioneering manoeuvre of Dr. Genuine Decrease, Professor of Molecular, Cellular & Developmental Biology at Yale University in Renewed Haven, CT. Let-7 was Read the rest of this entry »
